Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 199


Nuclear transport dysfunction: a common theme in amyotrophic lateral sclerosis and frontotemporal dementia.

Jovičić A, Paul JW 3rd, Gitler AD.

J Neurochem. 2016 Apr 17. doi: 10.1111/jnc.13642. [Epub ahead of print] Review.


Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD.

Boeynaems S, Bogaert E, Michiels E, Gijselinck I, Sieben A, Jovičić A, De Baets G, Scheveneels W, Steyaert J, Cuijt I, Verstrepen KJ, Callaerts P, Rousseau F, Schymkowitz J, Cruts M, Van Broeckhoven C, Van Damme P, Gitler AD, Robberecht W, Van Den Bosch L.

Sci Rep. 2016 Feb 12;6:20877. doi: 10.1038/srep20877.


Can Cluster-Boosted Regression Improve Prediction: Death and Length of Stay in the ICU?

Rouzbahman M, Jovicic A, Chignell M.

IEEE J Biomed Health Inform. 2016 Feb 3. [Epub ahead of print]


Lost information during the handover of critically injured trauma patients: a mixed-methods study.

Zakrison TL, Rosenbloom B, McFarlan A, Jovicic A, Soklaridis S, Allen C, Schulman C, Namias N, Rizoli S.

BMJ Qual Saf. 2015 Nov 6. pii: bmjqs-2014-003903. doi: 10.1136/bmjqs-2014-003903. [Epub ahead of print]


Identifying the content of home-based health behaviour change interventions for frail older people: a systematic review protocol.

Jovicic A, Gardner B, Belk C, Kharicha K, Iliffe S, Manthorpe J, Goodman C, Drennan V, Walters K.

Syst Rev. 2015 Nov 4;4:151. doi: 10.1186/s13643-015-0138-8.


Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS.

Jovičić A, Mertens J, Boeynaems S, Bogaert E, Chai N, Yamada SB, Paul JW 3rd, Sun S, Herdy JR, Bieri G, Kramer NJ, Gage FH, Van Den Bosch L, Robberecht W, Gitler AD.

Nat Neurosci. 2015 Sep;18(9):1226-9. doi: 10.1038/nn.4085.


User-centered design of a web-based self-management site for individuals with type 2 diabetes - providing a sense of control and community.

Yu CH, Parsons JA, Hall S, Newton D, Jovicic A, Lottridge D, Shah BR, Straus SE.

BMC Med Inform Decis Mak. 2014 Jul 23;14:60. doi: 10.1186/1472-6947-14-60.


The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Fares MB, Ait-Bouziad N, Dikiy I, Mbefo MK, Jovičić A, Kiely A, Holton JL, Lee SJ, Gitler AD, Eliezer D, Lashuel HA.

Hum Mol Genet. 2014 Sep 1;23(17):4491-509. doi: 10.1093/hmg/ddu165. Epub 2014 Apr 11.


TDP-43 in ALS: stay on target…almost there.

Jovičić A, Gitler AD.

Neuron. 2014 Feb 5;81(3):463-5. doi: 10.1016/j.neuron.2014.01.034.


Exome sequencing to identify de novo mutations in sporadic ALS trios.

Chesi A, Staahl BT, Jovičić A, Couthouis J, Fasolino M, Raphael AR, Yamazaki T, Elias L, Polak M, Kelly C, Williams KL, Fifita JA, Maragakis NJ, Nicholson GA, King OD, Reed R, Crabtree GR, Blair IP, Glass JD, Gitler AD.

Nat Neurosci. 2013 Jul;16(7):851-5. doi: 10.1038/nn.3412. Epub 2013 May 26.


Comprehensive expression analyses of neural cell-type-specific miRNAs identify new determinants of the specification and maintenance of neuronal phenotypes.

Jovičić A, Roshan R, Moisoi N, Pradervand S, Moser R, Pillai B, Luthi-Carter R.

J Neurosci. 2013 Mar 20;33(12):5127-37. doi: 10.1523/JNEUROSCI.0600-12.2013.


Knowledge translation of the HELPinKIDS clinical practice guideline for managing childhood vaccination pain: usability and knowledge uptake of educational materials directed to new parents.

Taddio A, Shah V, Leung E, Wang J, Parikh C, Smart S, Hetherington R, Ipp M, Riddell RP, Sgro M, Jovicic A, Franck L.

BMC Pediatr. 2013 Feb 8;13:23. doi: 10.1186/1471-2431-13-23.


MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.

Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos Mde F, Luthi-Carter R.

PLoS One. 2013;8(1):e54222. doi: 10.1371/journal.pone.0054222. Epub 2013 Jan 17.


Is Web-only self-care education sufficient for heart failure patients?

Jovicic A, Chignell M, Wu R, Straus SE.

AMIA Annu Symp Proc. 2009 Nov 14;2009:296-300.


[Protein S and ischemic brain disease].

Raicević R, Jovicić A, Mandić-Radić S, Dordević D, Marković L, Dincić E.

Vojnosanit Pregl. 2003 Jan-Feb;60(1):93-6. Serbian.


[The blood-brain barrier].

Dincić E, Jovicić A, Magdić B, Popović P, Dordević D, Raicević R.

Vojnosanit Pregl. 2002 Nov-Dec;59(6):633-41. Review. Serbian. No abstract available.


[The hemostatic system and ischemic brain disease--specific aspects associated with cerebral circulation and clinical implications].

Raicević R, Jovicić A, Mandić-Radić S, Dordević D.

Vojnosanit Pregl. 2002 Sep-Oct;59(5):523-9. Review. Serbian. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk